How should I investigate abnormal transaminases in patients with risk factors for, or clinical features of liver disease?
Further investigations are advised for any enzyme rise associated with risk factors for, or clinical evidence of liver disease except, where an apparent cause is found (hypertriglyceridaemia, diabetes, alcohol, overweight) for which a 6 month trial of appropriate intervention is recommended.